May 1st, 2012
With so many different interpretations to coding rules, your practice can’t afford not to create one. By Pam Brooks, CPC If coding were described as a color, it would be gray. Even with CPT®, ICD-9-CM, and HCPCS Level II guidelines, and despite regulatory guidance from the Centers for Medicare & Medicaid Services (CMS), the Office ...
In Billing
Feb 15th, 2010
The Centers for Medicare & Medicaid Services (CMS) has rendered outpatient intravenous insulin therapy (OIVIT) nationally non-covered by Medicare, effective Dec. 23, 2009. CMS says it will create a new HCPCS Level II code for use of this non-covered service that will be effective Dec. 23, 2009 and implemented with the April 2010 Integrated Outpatient Code ...
In CMS
Sep 30th, 2009
Outpatient intravenous insulin therapy (OIVIT) is to remain nationally noncovered. The Centers for Medicare & Medicaid Services (CMS) recently concluded that OIVIT does not improve health outcomes and is not reasonable and necessary for any indication. Pulse Insulin Therapy Remains Noncovered was last modified: July 5th, 2011 by admin aapc...
In Coding
Aug 3rd, 2009
Diabetes patients taking NovoLog® (HCPCS Level II code S5551 Insulin, most rapid onset (Lispro or Aspart); 5 units) can now use the insulin in their pump for up to six days. Diabetes care company Novo Nordisk announced Food and Drug Administration (FDA) approval of this labeling change July 21. The previous label allowed for NovoLog® ...
In Coding
Nov 18th, 2008
Let diabetic patients know Tyco Healthcare Group LP (Covidien) recalled one lot of ReliOn 31-gauge, 1cc insulin syringes due to possible mislabeling. According to a U.S. Food and Drug Administration Nov. 5 news release, there was a mix up during the packaging process and some syringes labeled for use with U-40 insulin were mixed with ...